Major pharmas show high interests in DGMIF’s ‘innovative renal cancer treatment technology’
The Daegu-Gyeongbuk Medical Innovation Foundation(Chairman Jae-Tae Lee, DGMIF) have drawn huge interests of major Korean and multinational pharmaceutical companies with the ‘innovative renal cancer treatment’ at the ‘InterBiz Bio-Partnering & Investment Forum 2017’ in Jeju Island between the 5th ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
